Page last updated: 2024-08-25

betulin and Liver Neoplasms

betulin has been researched along with Liver Neoplasms in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	3 (60.00)	2.80

Authors

Authors	Studies
Chen, S; Chen, Y; Fu, L; Zhang, L	1
Chen, Y; Chen, Z; Fan, M; Li, Y; Lin, J; Lin, Z; Lu, L; Shao, W; Yi, C; Zhou, Y	1
Cao, Y; Feng, F; Li, Z; Wang, L; Wang, X; Yin, F	1
Akasov, RA; Beloglazkina, EK; Burenina, OY; Erofeev, AS; Evteev, SA; Gorelkin, PV; Ivanenkov, YA; Klyachko, NL; Kovalev, SV; Lobov, AN; Lopatukhina, EV; Lopukhov, AV; Majouga, AG; Naumenko, VA; Pavlova, EN; Ryabaya, OO; Shkil', DO; Skvortsov, DA; Vaneev, AN; Yamansarov, EY	1
Choi, JE; Lim, SC; Oh, SH	1

Reviews

1 review(s) available for betulin and Liver Neoplasms

Article	Year
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential. Journal of medicinal chemistry, 2022, 10-13, Volume: 65, Issue:19 Topics: Carcinoma, Hepatocellular; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Interferons; Liver Neoplasms; Nucleotides; Organic Anion Transporters, Sodium-Dependent; Symporters; Virus Internalization	2022

Article

Year

Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.

Journal of medicinal chemistry, 2022, 10-13, Volume: 65, Issue:19

Topics: Carcinoma, Hepatocellular; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Interferons; Liver Neoplasms; Nucleotides; Organic Anion Transporters, Sodium-Dependent; Symporters; Virus Internalization

2022

Other Studies

4 other study(ies) available for betulin and Liver Neoplasms

Article	Year
SREBP2 inhibitor betulin sensitizes hepatocellular carcinoma to lenvatinib by inhibiting the mTOR/IL-1β pathway. Acta biochimica et biophysica Sinica, 2023, Jul-11, Volume: 55, Issue:9 Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Liver Neoplasms; Mice; Phenylurea Compounds; TOR Serine-Threonine Kinases	2023
SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity. Cell death & disease, 2019, 09-11, Volume: 10, Issue:9 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Drug Synergism; Gene Expression Regulation, Neoplastic; Glycolysis; Hep G2 Cells; Humans; Lipid Metabolism; Liver Neoplasms; Mice; Mice, Nude; Prognosis; Sorafenib; Sterol Regulatory Element Binding Protein 1; Transplantation, Heterologous; Triterpenes	2019
Discovery of Bivalent GalNAc-Conjugated Betulin as a Potent ASGPR-Directed Agent against Hepatocellular Carcinoma. Bioconjugate chemistry, 2021, 04-21, Volume: 32, Issue:4 Topics: Acetylgalactosamine; Antineoplastic Agents; Asialoglycoprotein Receptor; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Delivery Systems; Drug Discovery; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Hydrophobic and Hydrophilic Interactions; Liver Neoplasms; Molecular Docking Simulation; Surface Plasmon Resonance; Triterpenes	2021
Protection of betulin against cadmium-induced apoptosis in hepatoma cells. Toxicology, 2006, Mar-01, Volume: 220, Issue:1 Topics: Apoptosis; Cadmium; Carcinoma, Hepatocellular; Caspase 8; Caspases; Cell Fractionation; Cell Line, Tumor; Cell Survival; DNA Fragmentation; DNA, Neoplasm; Dose-Response Relationship, Drug; fas Receptor; Hepatocytes; Humans; Liver Neoplasms; Mitochondria; Reactive Oxygen Species; Triterpenes; Up-Regulation	2006